Clinical Trial Results Archive

Clinical Trial Results: July 2007

July 2	ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 2	Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
July 2	Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
July 2	Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
July 2	Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
July 2	DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
July 2	Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
July 2	Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
July 2	Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
July 2	Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
July 2	Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
July 2	Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
July 2	Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
July 2	ENDEAVOR IV Clinical Trial Meets Primary Endpoint
July 2	Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
July 2	Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
July 2	Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
July 3	Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 3	Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
July 3	Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
July 3	EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 3	Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
July 3	From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
July 3	Researchers Discover Method for Identifying How Cancer Evades the Immune System
July 3	Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
July 3	Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
July 3	Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
July 3	Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
July 3	Tercica to Present at Investment Conferences
July 5	Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
July 5	Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
July 5	Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
July 5	Avexa's Apricitabine Clinical Trial Update
July 5	Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
July 5	Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
July 5	Genzyme Announces Results of Clinical Trial of Hylastan
July 5	Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
July 5	GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
July 5	Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
July 5	Stanford Researchers Find Brain Pathway of Depression in Rats
July 5	NIEHS Researchers Identify Enzyme Critical in DNA Replication
July 5	Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 6	Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
July 6	TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
July 6	New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
July 6	New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
July 6	SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 6	BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
July 6	DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
July 6	Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
July 6	Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
July 6	Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
July 6	ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 9	Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
July 9	Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
July 9	TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
July 9	Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
July 9	MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
July 9	Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
July 9	Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 9	Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
July 9	Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 9	New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
July 9	Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
July 9	NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
July 9	AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
July 9	YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
July 9	International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
July 9	Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference
July 9	Aptuit Introduces Aptuit IVRS powered by Clarix, a Fully Web-Integrated Interactive Voice Response System Providing Customers with Easy Access to Real-Time Data
July 9	Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting System's Success in Mouse Model Reported in Cancer Cell
July 10	CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
July 10	Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
July 10	Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
July 10	Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
July 10	Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
July 10	Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
July 10	Protox Announces Positive Clinical Data from Prostate Cancer Study
July 10	AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
July 10	Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's Disease
July 10	BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
July 10	Molecular Target of Bradmer's Neuradiab Further Validated by Independent Findings
July 10	Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
July 11	Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
July 11	YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
July 11	Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
July 11	Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
July 11	BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
July 11	Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
July 11	Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
July 11	New Information on the Potential of Plasmin Shared at ISTH Congress
July 11	Antibiotics Don't Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections
July 11	Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
July 11	Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
July 11	Sygnis Pharma AG announces date for presentation of clinical results
July 11	Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
July 11	Cell Therapeutics, Inc. Management to Discuss Today's Announcement of Interim Pixantrone Study Results
July 11	Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
July 11	Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
July 12	Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
July 12	LAB International Announces Positive Results from its Growth Hormone Releasing Hormone (GHRH) Phase II Trial
July 12	ISI Announces Regional eCTD Readiness Workshops for Electronic Submissions
July 12	Progenics Selected to Present Clinical Results for Novel HIV Therapy PRO 140 at International Aids Conference
July 12	CardioVascular BioTherapeutics Completes Pre-clinical Stroke Research
July 12	Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
July 12	Stem Cell Clinic Publishes First Peer Reviewed Paper on Autism Stem Cell Therapy
July 12	Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting
July 12	City of Hope Selects TrialMaster to support clinical trials
July 12	Octagon Research Solutions Limited is Granted SME Status in EU
July 12	Acusphere Presents at Controlled Release Society
July 12	Celsion Reports Early Success with Second Drug
July 12	Bayer HealthCare Reports Positive Preclinical Study Results on Longer-Acting Recombinant Factor VIII Molecules
July 12	Karo Bio Half Year Report January - June 2007
July 13	Cytel Inc. Releases East 5 Clinical Trial Design System
July 16	Hollis-Eden Pharmaceuticals Reports Initial Results in Phase I Clinical Trial of HE3286 as New Type II Diabetes Treatment
July 16	CardioVascular BioTherapeutics to Provide Clinical Trial Details on July 19 Conference Call
July 16	Arpida Reports Positive Results of Second Pivotal Phase Iii Trial with Intravenous Iclaprim in CSSSI
July 16	Pharsight Releases Drug Model Explorer Version 1.6
July 16	Drug Delivery Company Acrux Announces the Results of Its Phase 2 Male Testosterone Replacement Lotion Trial
July 16	Can-Fite Reports Results of a Phase IIb Clinical Study in Rheumatoid Arthritis with CF101, an A3 Adenosine Receptor Agonist. The Results Support Further Clinical Development of CF101
July 16	BioLineRx Announces Results of Clinical Receptor-Occupancy Study of BL-1020, a First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
July 16	IBM Signs $1.4 Billion Global Strategic Outsourcing Agreement With AstraZeneca
July 16	Vernalis Reports Positive Outcome of a Phase IIA Trial of V3381 In Diabetic Neuropathic Pain
July 16	Study Finds COPD Patients Taking Inhaled Steroids are at Greater Risk for Severe Pneumonia
July 16	Long-Sought Adaptive Trial Predictability Announced: Cytel Inc., Tourtellotte Solutions Reveal Integrated Simulators
July 16	Data Supports Potential Mechanism for Gentium's Defibrotide in Cancer, Diabetic Nephropathy and Veno-Occlusive Disease
July 16	Amira Pharmaceuticals Announces Positive Initial Data From a Phase 1 Study of AM103, A Novel Product Candidate for the Treatment of Respiratory and Cardiovascular Disease
July 16	New Clinical Results Increase Market Potential of Cytotect
July 17	Elixir Pharmaceuticals Announces Presentation of Data in Programs to Treat and Prevent Metabolic Diseases
July 17	Idera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Rheumatoid Arthritis Models
July 17	Metabasis Therapeutics Announces CS-917 Phase 2b Clinical Trial Results and Reports on Status of Pradefovir
July 17	CVBT Announces Positive Pre-Clinical Results for Protein-Based Drug Candidate to Treat Osteoporosis
July 17	Secondary Endpoints of Phase II/III Study Confirm Clear Benefits from Treatment With removab(R) for Patients with Malignant Ascites
July 17	AVI BioPharma Announces Positive Pre-Clinical Study Results Presented at the 26th Annual Meeting of the American Society for Virology
July 17	Idera Pharmaceuticals Announces Publication of Study of Toll-Like Receptor 9 Agonist in Combination with Avastin(R) in Preclinical Colon Cancer Model
July 17	Nymox Announces New Drug Data to Be Presented at Upcoming U.S. Urology Meeting
July 17	Nextrials Selected by AlwaysOn as an AO 100 Top Private Company Award Winner
July 17	Sirtris Pharmaceuticals Presents Results of Studies of SIRT1 Activators at 6th Annual Metabolic Diseases Drug Discovery and Development World Summit, July 17, 2007
July 18	Nymox Announces New Drug Data to Be Presented at Upcoming U.S. Urology Meeting
July 18	BioSante Pharmaceuticals Announces New Findings For Potential Bird Flu Vaccine
July 18	PPD Completes First-in-Human Trial for Novel Statin
July 18	Anecortave Acetate Clinical Trial Data for Glaucoma Presented at World Congress of Glaucoma
July 18	Purdue Pharma Turns to Microsoft for Document Management Solution
July 18	TechnoVax Reports on a VLP Vaccine Designed to Protect Against the Devastating 1918 Pandemic Influenza As Well As a Novel Bivalent VLP Vaccine Candidate
July 18	BlueCielo ECM Solutions Releases InnoCielo View 2008
July 18	Definiens Reveals an Integrated Data Management Approach For Image Analysis in Life Sciences Enterprises
July 19	ImmuneRegen BioSciences, Inc. and Virion Systems, Inc. Continue Testing Viprovex and Tamiflu as Possible Influenza Co-Treatment
July 19	Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
July 19	Landmark Cimzia Data in Crohn's Disease Published in New England Journal of Medicine
July 19	Positive Preliminary Results of Phase IIb AK Study
July 19	Pivotal Cimzia Data in Crohn's Disease Published in New England Journal of Medicine
July 20	Journal of Clinical Oncology Publishes Data on Zolinza (vorinostat), Merck's Treatment for Advanced Cutaneous T-cell Lymphoma
July 20	Wyeth and Progenics Announce Positive Preliminary Results of Phase 1 Study of New Oral Formulation of Methylnaltrexone
July 20	Sorel Forge Selects Amadeus eQCM Software Solution
July 20	GlycoMimetics, Inc. Highlights Advances in Lead Drug Candidate for Sickle Cell Patients at International Glycobiology Conference
July 20	Samaritan Announces Positive Preliminary Results in a Phase IIb Study For Its Novel Oral HIV Entry Inhibitor
July 20	Improvement Following ADHD Treatment Sustained in Most Children, But Linked Problems Persist Into Adolescence -- Major Follow-up Study
July 20	New Data Show Tekturna and Diovan Used Together Provide Additive Blood Pressure Reductions
July 20	Pharsight Releases Drug Model Explorer Version 1.6
July 23	ANX-201 Combination Therapy Demonstrates Synergistic Inhibition of HIV-1 in Preclinical Tests
July 23	Nventa Announces Publication of Final Results of a Phase 2 Study of HspE7 in Cervical Dysplasia
July 23	Xencor Data Published in Journal of Immunology Demonstrate Selectivity of New Class of Inhibitors for Inflammatory Disease
July 23	Pluristem's PLX Cells Show Promise in Treating Limb Ischemia
July 23	Advanced Magnetics Announces Positive Results from Fourth Phase III Study of Ferumoxytol as an Intravenous Iron Replacement Therapeutic in Chronic Kidney Disease Patients
July 23	Paper in Cancer Biology & Therapy Confirms In Vitro Cytotoxic Effect of Alfacell's Onconase
July 23	New Interim Results Demonstrate High Response Rate With Fuzeon Plus Darunavir Regardless of Existing Protease Inhibitor Resistance
July 23	144-Week Data from Gilead's Study 934 Comparing Truvada to Combivir Both in Combination with Sustiva Presented At International AIDS Society Meeting in Sydney
July 23	MedImmune Announces Interim Phase 1 Study Results for Potential Asthma Therapy
July 23	Sygnis Announces Successful Completion of the Clinical IIa Study for AX200 in Stroke
July 23	New Data Suggest Boosted Invirase Has Similar Efficacy to Boosted Lopinavir in HIV Patients at 24 Weeks
July 23	Baxter Announces Preliminary Phase I/II Data for Seasonal Influenza Vaccine Candidate
July 23	SYGNIS successfully completes clinical study IIa for AX200 in stroke (AXIS)
July 24	Isentress (raltegravir), an Investigational Oral HIV Integrase Inhibitor, in Combination Therapy Demonstrated HIV RNA Reduction Comparable to Efavirenz in Treatment-Naive HIV-Positive Patients
July 24	Etrials EDC to Interface with Green Mountain Logic Labpas CT
July 24	Phase IIa Study Results Demonstrate that Once-Daily 200 mg Dosing of INCB9471 Provided Potent and Prolonged Antiviral Activity in HIV-Infected Patients
July 24	Starpharma Presents Positive Results of Clinical Study of VivaGel in Men at 4th International AIDS Society Conference
July 24	Vicriviroc Demonstrates Potent Viral Suppression Through 48 Weeks of Therapy in ACTG Phase II Study in Treatment-Experienced HIV Patients
July 24	Orexigen Therapeutics Reports Top-line 24 Week Results for Phase IIb Trial of Empatic to Treat Obesity
July 24	Protalex Announces Preliminary Results in Phase I Clinical Trial
July 24	Phase Forward and Sentrx Partner to Offer Integrated Drug Safety Services
July 24	OrexigenReports Top-line 24 Week Results for Ph IIb EMPATIC? Obesity Trial
July 24	Faster-Acting Antidepressants Closer to Becoming a Reality
July 25	New Head-to-Head Study Comparing Lexiva and Atazanavir Show Similar Efficacy and Lipid Changes
July 25	Analysis of Ushercell HIV Trials Reveals Difference in Seroconversion Groups Not Statistically Significant
July 25	BioSante Pharmaceuticals Announces Positive Resultsfor its CaP Technology for Use in Aesthetic Medicine
July 25	BioSante Pharmaceuticals Announces Positive Results for its CaP Technology for Use in Aesthetic Medicine
July 25	Targacept Presents Data from Tridmac Trial Showing Positive Effects of Mecamylamine as Augmentation Treatment for Depressed Patients
July 25	Animal Studies Show Promising Therapeutic Dosing Results Using an Antisense Agent to Treat Heart Disease
July 25	Actemra monotherapy demonstrates significant clinical benefit in patients with rheumatoid arthritis
July 25	Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference
July 25	AVI BioPharma Partner Global Therapeutics Announces Positive Pre-Clinical Results Shown Using Neugene Antisense Drug in Prevention of Cardiovascular Restenosis
July 25	The Journal of Hand Surgery Publishes Initial Phase III Data on Xiaflextm (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture
July 25	Fourth Actemra (tocilizumab) Phase III Study Demonstrates Significant Clinical Benefit in RA Patients
July 25	Progenics Presents Additional Positive Clinical Results for HIV-Entry Inhibitor PRO 140 at International AIDS Meeting
July 25	Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show
July 25	Treating HIV-Infected Infants Early Helps Them Live Longer
July 25	CytoDyn Study of Bird Flu Vaccines Illustrates Subsidiary's Unique Opportunity
July 25	Delphian Pharma Announces-Discovery of Novel Anti-tumor Antimitotic Agents That Also Reverse Tumor Resistance
July 26	First Peer-Reviewed Preclinical and Early Phase 1 Results for NKTR-118 (oral PEG-naloxol) to be Presented at Upcoming Pharmacology and Pain Management Meetings
July 26	Anti-Tumor Activity and Pharmacokinetic Properties of NKTR-102 (PEG-irinotecan) to be Presented at Upcoming Oncology Meeting
July 26	Ubisol-Aqua: Coenzyme Q10 May Prevent Toxicity of HIV Drug Therapy
July 26	OctoPlus Announces Promising Results for Locteron Phase IIa Clinical Study
July 26	Avexa Releases ATC Phase IIb Clinical Trial Update
July 26	Controversy Over Use of Antipsychotic Drugs for Dementia, From the Harvard Mental Health Letter
July 26	OctoPlus announces promising results for Locteron Phase IIa clinical study
July 26	Yale School of Medicine Shows First Detailed View of Molecular Structure May Usher in New Class of Cancer Drugs
July 27	Genaera Corporation Presents New Preclinical Data for Obesity Compound Trodusquemine (MSI-1436) at CBI Conference
July 27	Gene Logic Drug Candidate Shows Positive In Vivo Test Results
July 27	Positive Aggrastat Results Versus Integrilinr Featured in American Heart Journal
July 30	Intellect Neurosciences, Inc. Announces the Release of Audited Data for its Drug Candidate, Oxigon, From a Single Dose Phase I Trial
July 30	Study Discovers Link Between Increased White Matter in the Brain and Poor Motor Skills in Children With Autism
July 30	Can-Fite: Pre-clinical Studies Demonstrate that the Excipients Used in the Placebo and CF101 Drug Enhanced the Anti-inflammatory Effect of Methotrexate (MTX)
July 30	Investigational Anti-Inflammatory Drug Produces Promising Results in Animal Studies
July 30	ClinPhone and LabPas CT Agree to Interface
July 30	AlphaVax Announces Interim Results From Phase 1 Influenza Vaccine Clinical Trial
July 31	Infringement Claims Against DATATRAK Dismissed
July 31	Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Eye Disorders
July 31	OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical Trial Plans
July 31	New Study Finds Tindamax to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
July 31	Phase Forward Signs Multi-Year Enterprise Agreement with ICON
July 31	Preliminary Data Add New Mechanistic Insights to Activity of Anthrax Anti-Toxin, Valortim
July 31	The International Journal of Cancer Publishes Studies on Generex Biotechnology's Anti-cancer Activity of Its Immunotherapeutic Vaccine
July 31	OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical Trial Plans
July 31	Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process

Clinical Trial Results Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec

More News Resources

Pharma News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals

	A to Z Drug List	Drugs by Condition	Pill Identifier	Drug Interactions Checker	Medical Encyclopedia	Medical Dictionary	Pharmaceutical News & Articles	Community Forums
Welcome Guest\|Register or Sign In My Viewing History \| My Drug List \| My Interactions Lists \| Member Offers